Vertex is smarting from a pain portfolio setback Shares in Vertex Pharma have come under pressure after one of its non-opioid pain candidates failed to move the needle in a mid-stage trial.

Shares in #VertexPharma have come under pressure after one of its non-opioid #pain candidates failed to move the needle in a mid-stage trial.

pharmaphorum.com/news/vertex-...

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger Earnings - The Wall Street Journal Vertex Stock Falls After Pain-Drug Setback, Despite Stronger Earnings  The Wall Street Journal

Click Subscribe #VertexPharma #StockMarket #Investing #Pharmaceuticals #EarningsReport

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger Earnings - The Wall Street Journal Vertex Stock Falls After Pain-Drug Setback, Despite Stronger Earnings  The Wall Street Journal

Click Subscribe #VertexPharma #StockMarket #EarningsReport #HealthcareNews #PainManagement

New cystic fibrosis triple from Vertex backed for NHS use Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.

#cysticfibrosis #Vertex #NHSuse #VertexPharma #NHS #England #Wales #CFpatients #Reimbursement #NICE #NICEapproved #NICEguidance #Alyftrek #deutivacaftor #tezacaftor #vanzacaftor #F508delmutation #CFTRgene #cysticfibrosispatients #SKYLINE102 #SKYLINE103
pharmaphorum.com/news/new-cys...

New cystic fibrosis triple from Vertex backed for NHS use Vertex has won NICE's backing for a new cystic fibrosis therapy, Alyftrek, that could be an option for 89% of NHS patients with the genetic disorder.

#VertexPharma has added another exon-skipping therapy for #cysticfibrosis to its portfolio of drugs that can be prescribed by the #NHS in England and Wales for patients with the genetic disorder.

pharmaphorum.com/news/new-cys...

A #celltherapy developed by #VertexPharma has allowed 10 of 12 patients with #type1diabetes to control their blood sugar without insulin, according to new data from a phase 1/2 trial.

pharmaphorum.com/news/ada-ver...

Honored to speak at #ASCRS2025 on behalf of Vertex Pharmaceuticals about the new FDA-approved non-opioid pain option. These conferences keep us sharp and our patients safer. Here’s to innovation that puts care first. #ColorectalCare #VertexPharma #DrTushyTouchUp

Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom - Barron's Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom  Barron's

Click Subscribe #PharmaStocks #EliLilly #VertexPharma #AbbVie #Tariffs